Stacey Marie Burdett, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 126 6th Ave Sw, Ronan, MT 59864 Phone: 406-676-3600 Fax: 406-676-3738 |
Mrs. Jenaia Mae Mcgreevey, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 104 Main St Sw, Ronan, MT 59864 Phone: 406-676-4325 |
Margaret A Martino, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 126 6th Ave Sw, Ronan, MT 59864 Phone: 406-676-3600 Fax: 406-676-3738 |
News Archive
Next time you need to choose between vegetable oil and margarine in that favorite recipe, think about your health and reach for the oil. While the question of whether vitamin E prevents or promotes cancer has been widely debated in scientific journals and in the news media, scientists at the Center for Cancer Prevention Research, at Rutgers Mario School of Pharmacy, and the Cancer Institute of New Jersey, believe that two forms of vitamin E - gamma and delta-tocopherols - found in soybean, canola and corn oils as well as nuts do prevent colon, lung, breast and prostate cancers.
Penn Pharma and Xcelience, LLC today announced that the two companies have entered into a joint venture agreement to provide Capsugel's Xcelodose® precision powder micro-dosing system technology on a global basis.
In support of the Government of Canada's commitment to strengthening Canada's healthcare system, the Honourable Leona Aglukkaq, Minister of Health, announced today funding for 25 policy-relevant research projects across six provinces.
If your neighborhood is well-lit at night, you may not be sleeping well, according to a study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.
Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.
› Verified 8 days ago